Yoshida K, Kubo I, Kiyomi A, Homma Y, et al. Clinical Determinants Influencing First-line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma in Japan. Anticancer Res 2026;46:5589-5597.
PMID: 42823164